Form 4: Cadre Holdings CEO Sells $6.3M in Stock

Cadre Holdings, Inc. CEO and Chairman Warren B. Kanders reported selling 200,000 shares of common stock for approximately $6.3 million in March 2026.

Summary

• Warren B. Kanders, CEO, Chairman, Director, and 10% Owner of Cadre Holdings, Inc. (CDRE), reported two sales of common stock.
• On March 20, 2026, 100,000 shares were sold at a weighted average price of $31.4 per share, totaling approximately $3,140,000.
• On March 23, 2026, an additional 100,000 shares were sold at a weighted average price of $31.93 per share, totaling approximately $3,193,000.
• The total value of shares sold across both transactions is approximately $6,333,000.
• These transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, Kanders indirectly beneficially owns 9,917,039 shares through Kanders SAF, LLC, 1,305,650 shares through Warren B. Kanders Roth IRA, and 23,450 shares through Allison Kanders Roth IRA (spouse).
• Kanders also directly beneficially owns 22,888 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the disclosure that these sales were made pursuant to a Rule 10b5-1 plan suggests a pre-arranged transaction for personal financial planning rather than a reaction to immediate company-specific news.

Negatives

• The sale of 200,000 shares by a high-ranking insider (CEO and Chairman) could be perceived negatively by some investors, despite being part of a pre-planned Rule 10b5-1 arrangement.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider selling, particularly by a CEO and Chairman, often draws investor attention. However, the indication that these transactions were executed under a Rule 10b5-1 plan suggests the sales were pre-scheduled and not necessarily based on new, non-public information, which typically mitigates the perceived negative signal compared to unscheduled sales.

Related Party Transactions

• Warren B. Kanders indirectly beneficially owns 23,450 shares through Allison Kanders Roth IRA, where Allison Kanders is the reporting person's spouse.

Stakeholder Impact

• Shareholders may interpret the insider selling differently; some may view it as a normal part of executive compensation and diversification, especially given the 10b5-1 plan, while others might see it as a potential lack of confidence, though the latter is less likely with a pre-planned sale.

Key Dates

Recommendation

The insider sale by the CEO and Chairman, while notable, was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on recent material non-public information. This mitigates the typical negative signal of insider selling. Given the context, this transaction alone does not provide a strong enough signal to warrant a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as investors should consider broader company fundamentals.

Keywords

Cadre Holdings, CDRE, insider trading, stock sale, Form 4, Warren B. Kanders, 10b5-1 plan